Title:
【発明の名称】キシナホ酸サルメテロール製剤のエアゾル容器
Document Type and Number:
Japanese Patent JP2003534063
Kind Code:
A
Abstract:
The invention relates inter alia to a container sealed with a valve, which contains a pharmaceutical aerosol formulation comprising (A) particulate salmeterol xinafoate in suspension in (B) a liquefied propellant gas which is 1,1,1,2,3,3,3-heptafluoro-n-propane or 1,1,1,2-tetrafluoroethane and mixtures thereof; said container characterised in that the formulation is substantially anhydrous and remains so over a period of 12 months when stored at 25° C. and at relative humidity of 60%. Preferably the valve is characterised in that it contains one or more valve seals substantially constructed from a polymer of ethylene propylene diene monomer (EPDM).
Inventors:
Crips, Alan, Leslie
Godfrey, Anne, Pauline
Otto Langui, David, Michael
Godfrey, Anne, Pauline
Otto Langui, David, Michael
Application Number:
JP2001585855A
Publication Date:
November 18, 2003
Filing Date:
May 22, 2001
Export Citation:
Assignee:
GLAXO GROUP LIMITED
International Classes:
A61J1/05; A61J1/14; A61J3/00; A61K9/72; A61K31/137; A61K47/06; A61M15/00; A61P11/00; A61P11/06; A61P29/00; B65D77/00; B65D83/34; B65D81/26; B65D83/14; B65D83/36; A61K9/00; (IPC1-7): A61J3/00; A61J1/05; A61J1/14; A61K9/72; A61K31/137; A61K47/06; A61M15/00; A61P11/00; A61P11/06; A61P29/00; B65D83/34; B65D83/36
Domestic Patent References:
JP2002532216A | 2002-10-02 | |||
JP2003506285A | 2003-02-18 | |||
JPH01137883A | 1989-05-30 | |||
JPS58194159A | 1983-11-12 | |||
JPH11285519A | 1999-10-19 | |||
JPH11206850A | 1999-08-03 |
Foreign References:
WO1996032345A1 | 1996-10-17 | |||
US2534636A | 1950-12-19 | |||
WO1999006303A1 | 1999-02-11 |
Attorney, Agent or Firm:
Yusuke Hiraki (2 outside)